AstraZeneca PLC ADR (AZN) is a publicly traded drug manufacturers-general business based in the US. It opened the day at 67.28 after a previous close of 67.94. During the day the price has varied from a low of 66.71 to a high of 67.85. The latest price was 67.42 (25 minute delay). AstraZeneca PLC ADR is listed on the NASDAQ and employs 83,500 staff. All prices are listed in US Dollars.
How to buy shares in AstraZeneca PLC ADR
Choose a platform.If you're a beginner, our stock trading table below can help you choose.
Open your account.Provide your personal information and sign up.
Confirm your payment details.You'll need to fund your account with a bank transfer, debit card or credit card.
Search the platform for stock code:AZN in this case.
Research stocks.The platform should provide the latest information available.
Buy your stocks.Place a market order or limit order with your preferred number of shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving license and a means of payment.
Our top picks for buying AstraZeneca PLC ADR stock
Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Is it a good time to buy AstraZeneca PLC ADR stock?
Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
AstraZeneca PLC ADR stock price (NASDAQ:AZN)
Use our graph to track the performance of AZN stocks over time.
Share price volatility
Over the last 12 months, AstraZeneca PLC ADR's shares have ranged in value from as little as $52.4102 up to $76.0605. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AstraZeneca PLC ADR's is 0.1682. This would suggest that AstraZeneca PLC ADR's shares are less volatile than average (for this exchange).
Historical closes compared with the last close of 67.42
1 week (2023-09-21)
0.60%
1 month (2023-08-29)
-2.49%
3 months (2023-06-29)
-4.84%
6 months (2023-03-29)
-1.78%
1 year (2022-09-29)
22.78%
2 years (2021-09-29)
12.99%
3 years (2020-09-29)
22.34%
5 years (2018-09-28)
70.38%
Buy AstraZeneca PLC ADR stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is AstraZeneca PLC ADR under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the AstraZeneca PLC ADR P/E ratio, PEG ratio and EBITDA
AstraZeneca PLC ADR's current stock price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, AstraZeneca PLC ADR stocks trade at around 34x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of September 25, 2023 (21.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
AstraZeneca PLC ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3764. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into AstraZeneca PLC ADR's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
AstraZeneca PLC ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $17.6 billion.
The EBITDA is a measure of a AstraZeneca PLC ADR's overall financial performance and is widely used to measure a its profitability.
Forward annual dividend yield: 2.13% of stock value
Dividend payout ratio: 40.62% of net profits
AstraZeneca PLC ADR has recently paid out dividends equivalent to 2.13% of its share value annually.
AstraZeneca PLC ADR has paid out, on average, around 40.62% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.13% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 2.13% return on their shares, in the form of dividend payments. In AstraZeneca PLC ADR's case, that would currently equate to about 2.9 per share.
While AstraZeneca PLC ADR's payout ratio might seem fairly standard, it's worth remembering that it may be investing much of the rest of its net profits in future growth.
AstraZeneca PLC ADR's most recent dividend payout was on 11 September 2023. The latest dividend was paid out to all shareholders who bought their shares by 10 August 2023 (the "ex-dividend date").
Currently 0.006% of AstraZeneca PLC ADR shares are held by insiders and 17.163% by institutions.
AstraZeneca PLC ADR's fiscal year ends in December.
AstraZeneca PLC ADR's address is: 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA
Have AstraZeneca PLC ADR's shares ever split?
AstraZeneca PLC ADR's shares were split on a 2:1 basis on 27 July 2015. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your AstraZeneca PLC ADR shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for AstraZeneca PLC ADR shares which in turn could have impacted AstraZeneca PLC ADR's share price.
It's as easy to sell AstraZeneca PLC ADR as it is to buy! Here's how to sell AstraZeneca PLC ADR stocks that you already own.
Open your investment app. If you've got one with desktop access, you can log in online
Go to your portfolio. This should be in the main menu
Find your shares. You may be able to search your portfolio
Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
Sell your AstraZeneca PLC ADR shares. Your investment platform will let you know when your shares are sold
Most dealing providers will let you use your debit card to top up your account and buy shares. The main ways are with a debit card, bank transfer or with Apple/Google Pay.
The easiest way to get hold of some AstraZeneca PLC ADR shares is to sign up for a stock trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in AstraZeneca PLC ADR shares.
How likely would you be to recommend finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
Advertiser Disclosure
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
Finder Award
Finder Award
